Search for a command to run...
Boston Bio Systems Ltd. is significantly underperforming compared to its peers, as evidenced by its negative PE ratio, zero revenue growth, and lack of profitability metrics. Among its peers, Poly Medicure Ltd. stands out as the leader in profitability and growth, while several companies exhibit concerning financial weaknesses, such as high PE ratios without corresponding earnings.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Boston Bio Systems Ltd. | ₹8.91 | ₹6.24Cr | -11.39 | - | - |
POLYMED | ₹2,072.30 | ₹20,997.79Cr | 63.37 | 20.37% | 0.06 |
LAXMIDENTL | ₹340.30 | ₹1,870.36Cr | 100.52 | 21.79% | 0.99 |
Prevest Denpro Ltd. | ₹569.55 | ₹683.63Cr | 37.56 | 25.24% | - |
Hemant Surgical Industries Ltd. | ₹297.80 | ₹310.90Cr | 38.24 | - | - |
NURECA | ₹241.55 | ₹241.55Cr | -184.25 | -1.06% | 0.00 |
Raaj Medisafe India Ltd. | ₹84.59 | ₹111.77Cr | 18.23 | - | - |